Table 4.
CT/NG | TV | S. haematobium | |||||||
---|---|---|---|---|---|---|---|---|---|
NAAT+ | NAAT− | Total | NAAT+ | NAAT− | Total | Urine+ | Urine− | Total | |
Symptomatic | 4 | 75 | 79 | 16 | 65 | 81 | 11 | 72 | 83 |
Asymptomatic | 12 | 260 | 272 | 36 | 240 | 276 | 53 | 231 | 284 |
Total | 16 | 335 | 351 | 52 | 305 | 357 | 64 | 303 | 367 |
Sensitivity | (4/16) = 25% | (16/52) = 31% | (11/64) = 17% | ||||||
Specificity | (260/335) = 78% | (240/305) = 79% | (231/303) = 76% |
CT/NG = chlamydia or gonorrhea (Chlamydia trachomatis or Neisseria gonorrhoeae); NAAT = nucleic acid amplification test; STI = sexually transmitted infection; TV = trichomoniasis (Trichomonas vaginalis). For each infection of interest, syndromic recognition (defined as the presence of any urogenital symptom in patient reports) was compared against the appropriate gold standard laboratory test: NAAT for STIs and urine microscopy for schistosomiasis.